We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Breakthrough Device Supports AVF in Hemodialysis Patients

By HospiMedica International staff writers
Posted on 22 Jun 2020
Print article
Image: Breakthrough Device Supports AVF in Hemodialysis Patients (Photo courtesy of Laminate Medical)
Image: Breakthrough Device Supports AVF in Hemodialysis Patients (Photo courtesy of Laminate Medical)
A novel support mesh addresses the high rate of primary arteriovenous fistulas (AVF) failures and repeat procedures experienced by hemodialysis patients.

The Laminate Medical (Tel Aviv, Israel) VasQ External Support is a nickel titanium (nitinol) device designed to maintain the optimal configuration of the AVF anastomosis during remodeling, and promote outward wall thickening downstream during the critical weeks of maturation post-surgery and for eventual use during hemodialysis. Implanted during the AVF creation surgery, the VasQ results in a more laminar flow transition, a structurally reinforced juxta-anastomotic segment, venous tapering for smooth transition flow to the dilated fistula, and an arterial arch that guides blood flow towards the vein.

While AVFs are the preferred option for hemodialysis patients to enable effective treatment due to their long-term benefits, they have the lowest probability of actually becoming usable for hemodialysis in the short-term, with success rates as low as 40% at one-year. However, studies show that AVFs created in conjunction with VasQ External Support placement have consistently reported success rates as high as 86% or better by six months. The VasQ External Support has received breakthrough device by the US Food and Drug Administration (FDA; Silver Spring, MD, USA).

“Following a very successful expansion in Europe to treat forearm fistula patients with VasQ, and excellent clinical outcomes that were presented in international conferences, the inclusion of forearm fistula patients in the pivotal study marks an important step toward VasQ market clearance in the USA and a promising milestone for patients with kidney failure”, said Tammy Gilon, CEO of Laminate Medical.

“VasQ promises to be a new standard of care for fistula creation to give my hemodialysis patients the greatest probability of success,” said vascular surgeon Ellen Dillavou, MD of Duke University (Durham, NC, USA). “The device has performed as expected in my study patients so far, and I look forward to continue to utilize it once commercially available in the USA.”
An AVF is the most recommended access for kidney disease patients undergoing dialysis, created by connecting a patient's vein and artery to form a long-lasting site through which blood can be removed and returned. After the creation of an AVF, blood flow increases immediately, reaching 700–1,000 mL/min within one month. Both the artery and the vein dilate and elongate in response to the greater blood flow and shear stress, but the vein dilates more. When the vein is large enough to allow cannulation, the fistula is defined as mature.

Related Links:
Laminate Medical
US Food and Drug Administration


Gold Supplier
Enteral Feeding Pump
SENTINELplus
New
X-Ray Image Acquisition Software
dicomPACS DX-R
New
Vital Signs Monitor
Aurus 20 A
New
Eye Protector
Biliband

Print article

Channels

AI

view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Surgical Techniques

view channel
Image: The neuro-chip with soft implantable electrodes could manage brain disorders (Photo courtesy of EPFL)

Implantable Neuro-Chip Uses Machine Learning Algorithm to Detect and Treat Neurological Disorders

Using a combination of low-power chip design, machine learning algorithms, and soft implantable electrodes, researchers have produced a neural interface that can identify and suppress symptoms of different... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.